Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Big Ten Cancer Research Consortium
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb
Duke University
Incyte Corporation
Bristol-Myers Squibb
GlaxoSmithKline
Inspirna, Inc.
Yale University
Xencor, Inc.
Bristol-Myers Squibb
Bristol-Myers Squibb
Lung Cancer Group Cologne
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Gritstone bio, Inc.
Gritstone bio, Inc.
Bristol-Myers Squibb
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Incyte Corporation
Jounce Therapeutics, Inc.
MacroGenics
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Duke University
NYU Langone Health
Bristol-Myers Squibb
Bristol-Myers Squibb
University of Utah
Bristol-Myers Squibb